Abstract:In this collection, we aimed to enhance our understanding of epithelial-mesenchymal plasticity (EMP), primarily through the lens of the mesenchymal to epithelial transition (MET) and its implications in various biological contexts, especially cancer progression. These studies collectively highlight the complex interplay of molecular pathways and signaling networks that govern EMP, underlining the importance of these transitions in tumor biology and tissue homeostasis. While no particular article in this collection specifically focused on MET, they presented novel insights on EMT from different perspectives.For example, one article explores how circFGGY, a circular RNA, influences hepatocellular carcinoma by regulating the miR-545-3p/Smad7 axis, ultimately inhibiting cell growth, invasion, and the EMT process (Feng et al., 2022) by functional disrupting the TGFβ pathway. Upregulation of Smad7 by circFGGY caused an increased TGFβ activity, which was then in turn inhibited by miR-545-3p acting as antagonist of both circFGGY and Smad7. This aligns with the existing literature that highlights the role of non-coding RNAs in regulating EMT. Specifically, the microRNA miR-200 family is known to help maintain epithelial characteristics and prevent EMT by targeting key transcription factors like ZEB1 and ZEB2 (Brabletz et al., 2018). Identifying circFGGY as a tumor suppressor suggests that non-coding RNAs could be valuable targets for developing new therapeutic strategies against EMT in cancer.Another study focuses on identifying EMT-related genes and their prognostic significance in lower-grade gliomas, revealing how specific gene expressions correlate with tumor behavior and treatment responses (Wu et al., 2022). Notably, expression patterns of EMT-related gene panels (EMTsig) revealed potential functional interactions of adjacent non-tumor tissue during EMT and malignant LGG progression. Moreover, EMTsig can have its use as prognostic tool for predicitng efficacy of chemo-, targeted drug, and ICB therapies.This finding is consistent with previous research indicating that high levels of EMT-associated genes are often linked to poor prognosis and increased metastatic potential in various cancers (Kalluri and Weinberg, 2009). Recognizing these molecular signatures can aid in tailoring therapeutic strategies to individual patient profiles.The research on ameloblastin and its interactions with the extracellular matrix (ECM) extends the understanding of EMP beyond traditional concepts (Reseland et al., 2023). By examining how EMT and ECM interplay, this study suggests that manipulating these interactions could yield insights into both tissue regeneration and cancer biology. Previous studies have shown that the ECM plays a critical role in regulating EMT by providing mechanical and biochemical cues that influence cellular behavior (Tzanakakis et al., 2018). Furthermore, another investigation looks at how EMP influences cancer spreading patterns across different types of tumors (Wang and Yan, 2024). This study explains how strong hysteresis influences the MET process to become a slow process, leading to multiple intermediate stages between the complete epithelial and mesenchymal states, thereby indicating that a transient "hybrid epithelial/mesenchymal phenotype occurs in some if not most cancer cell types. They propose that EMT is controlled by hysteretic control mechanisms and can be defined in 4 subtypes with various hysteretic control. This research aligns with established knowledge that the dynamic transition between epithelial and mesenchymal states facilitates cancer cell dissemination and metastasis (Yang andWeinberg, 2008, Celia-Terrassa et al., 2018). Understanding these patterns is vital for developing targeted interventions that consider the plasticity of cancer cells.Additionally, a review discussing plasticity in cell migration modes across development, physiology, and disease emphasizes how EMP affects cellular behaviors in various contexts (Pourjafar and Tiwari, 2024). By exploring different migration modes influenced by EMP, this study highlights the adaptability of tumor cells to environmental cues, which is essential for formulating effective therapeutic strategies against cancer metastasis. Research indicates that cancer cells can switch between different migration modes, such as collective and individual migration, a key aspect of their plasticity that contributes to metastatic potential (Friedl andGilmour, 2009, Friedl andAlexander, 2011).Finally, a case report detailing the immunologic and molecular landscape of a unique cancer presentation underscores the complexity of EMP in tumor biology and the need for personalized treatment approaches (Riedinger et al., 2024). This aligns with the growing understanding that the tumor microenvironment, including immune cell interactions, plays a critical role in regulating EMT and cancer progression (Quail and J -Abstract Truncated-

Epithelial‐to‐Mesenchymal Transition as a Learning Paradigm of Cell Biology

The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview

Epithelial-mesenchymal Transition (EMT): A Biological Process in the Development, Stem Cell Differentiation, and Tumorigenesis

The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems

dbEMT 2.0: an updated database for epithelial-mesenchymal transition genes with experimentally verified information and pre-calculated regulation information for cancer metastasis

How studies in developmental epithelial-mesenchymal transition and mesenchymal-epithelial transition inspired new research paradigms in biomedicine

Mechanism and regulation of epithelial–mesenchymal transition in cancer

Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

The epithelial–mesenchymal transition: new insights in signaling, development, and disease

Epithelial–mesenchymal transition and its transcription factors

Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies

Guidelines and definitions for research on epithelial–mesenchymal transition

Investigating epithelial-to-mesenchymal transition with integrated computational and experimental approaches

Editorial: Understanding the mesenchymal to epithelial transition: a much needed angle for epithelial mesenchymal plasticity

Spatial and Temporal Relationship between Epithelial–Mesenchymal Transition (EMT) and Stem Cells in Cancer

Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit.

Biomarkers for epithelial-mesenchymal transitions